Zhitong Finance App News, Shengnuo Biotech (688117.SH) issued an announcement. Chengdu Shengnuo Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received a “Drug Registration Certificate” for linaclotide capsules issued by the State Drug Administration.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.